Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document

PUBLICATIONS 2002

 

634.      Andreassen, C.N., Alsner, J. & Overgaard, J.: Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiotherapy and Oncology 64: 131-140, 2002.

635.      Bentzen, L.N.: Imaging of tumour microenvironment; A study of experimental and human tumours. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 49 pages, 2002.

636.      Bentzen, L., Keiding, S., Horsman, M.R.,Gronroos, T.,  Hansen, S.B. & Overgaard, J: Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volumes and carbogen breathing. Acta Oncologica. 41: 304-312, 2002.

637.      Borre, M.: A study of prostate cancer II: The prognostic role of biological markers in patients subjected to watchful waiting. dr. med. Thesis, Faculty of Health Sciences, University of Aarhus, 65 pages2002.

638.      Bundgaard, T., Rossen, K., Henriksen, S.D., Charabi, S., Søgaard, H. & Grau, C.: Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity. Head Neck 24: 656-660, 2002.

639.      Gregersen, H., Lundby, L. & Overgaard, J.: Early and late effects of irradiation on morphometry and residual strain of mouse rectum. Dig. Dis. Sci. 47:1472-1479, 2002.

640.      Hansen, L.L., Jensen, L.L., Dimitrakakis, C., Michalas, S., Gilbert, F., Barber, H.R.K., Overgaard, J. & Arzimanoglou, I.I.: Allelic imbalance in selected chromosomal regions in ovarian cancer. Cancer Genet Cytogenet 139: 1-8, 2002.

641.      Harbo, G., Bundgaard, T., Søgaard, H., Pedersen, D. & Overgaard, J.: Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol 27: 512-516, 2002. 

642.      Harbo, G., Bundgaard, T., Overgaard, J. & Grau, C.: Comparison of two T-classification systems for sino-nasal carcinoma.  Clinical Otolaryngol 27: 254-259, 2002.

643.      Holten-Andersen, M.N., Christensen, I.J, Nielsen, H.J., Stephens, R.W., Jensen, V., Nielsen, O.H., Sørensen, S., Overgaard, J., Lilja, H., Harris, A., Murphy, G. & Brünner, N.: Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin. Cancer Res. 8: 156-164, 2002.

644.      Honoré, H.B.: Models for optimization of modern radiotherapy. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 62 pages, 2002.

645.      Honoré, H., Bentzen, S.M., Møller, K. & Grau, C.: Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk estimation. Radiother. Oncol. 65: 9-16, 2002.

646.      Horsman, M.R. & Murata, R.: Combination of vascular tageting agents with thermal and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 54: 1518-1523, 2002.

647.      Horsman, M.R. & Overgaard, J:. The oxygen effect and the tumour microenvironment. In: G.G.Steel (ed.), Basic Clinical Radiobiology for Radiation Oncologists. 3rd ed., Edward Arnold, London, pp. 158-168, 2002.

648.      Horsman, M.R. & Overgaard, J.:Overcoming tumour radioresistance resulting from hypoxia. In: G.G.Steel (ed.), Basic Clinical Radiobiology for Radiation Oncologists. 3rd ed., Edward Arnold, London, pp. 169-181, 2002.

649.      Jensen, A.R.: A comparative population based study on breast cancer patients in Denmark and Sweden. Aspects of early diagnosis, axillary surgery and registration. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 190 pages, 2002.

650.      Jensen, A.R. Mainz, J. & Overgaard, J.: Impact of delay on diagnosis and treatment of primary lung cancer. Acta Oncologica 41: 147-152, 2002.

651.      Jensen, A.R., Overgaard, J. & Storm, H.H.: Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur. J. Cancer Prev. 11: 359-364, 2002.

652.      Johansen, H., Overgaard, J. & Sell, A.: Sigvard Kaae - in memoriam. Ugeskr. Læg. 164: 95, 2002.

653.      Johansen, J., Overgaard, J., Rose, C., Engelholm, S.A., Gadeberg, C.C., Kjær, M., Kamby, C., Juul-Christensen, J., Blichert-Toft, M. & Overgaard, M.: Cosmetic outcome and breast morbidity in breast-conserving treatment. Results from the Danish DBCG-82TM national randomized trial in breast cancer. Acta Oncologica 41: 369-380, 2002.

654.      Johansen, L.V., Grau, C. & Overgaard, J.: Supraglottic carcinoma. Patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int. J. Radiat. Oncol. Biol. Phys. 53: 948-958, 2002

655.      Johansen, L.V., Grau, C. & Overgaard, J.: Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiotherapy and Oncology 63: 257-267, 2002.

656.      Knap, M.: Radical cystectomy in bladder cancer. Indication, prognosis, morbidity. Analysis of a consecutive cohort of patients treated at Aarhus University Hospital 1992-1998. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 129 pages, 2002.

657.      Kragh, M., Quistorff, B., Horsman, M.R. and Kristjansen, P.E.G.: Acute effects of vascular modifying agents in solid tumors assessed by non-invasive laser Doppler flowmetry (LDF) and near infrared spectroscopy (NIRS). Neoplasia 4: 263-267, 2002.

658.      Kaarstad, K., Bender, D., Bentzen, L., Munk, O.L. & Keiding, S.: Metabolic fate of 2-(18F)fluoro-2-deoxy-D-glucose in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma. J. Nucl. Med. 43: 940-947, 2002.

659.      Lauridsen, M.C.: Treatment of early breast cancer: Aspects of physiotherapy and sentinel lymph node biopsy. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 144 pages, 2002.

660.      Macbeth, F. & Overgaard, J.: Expert reviews, systematic reviews and meta-analyses (editorial). Radiotherapy and  Oncology 64: 233-234, 2002.

661.      Offersen, B.V.: Methodological and prognostic evaluation of immunohistochemical assessment of angiogenesis in human carcinomas. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 50 pages, 2002.

662.      Offersen, B.V., Borre, M. Sørensen, F.B. & Overgaard, J.: Comparison of methods of microvascular staining and quantification in prostate carcinoma: Relevance to prognosis. APMIS 110: 177-185, 2002.

663.      Offersen, B.V., Knap, M.M., Marcussen, N., Horsman, M.R., Hamilton-Dutoit, S. & Overgaard, J.: Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis. Brit. J. Cancer 87: 1422-1430, 2002.

664.      Offersen, B.V., Sørensen, F.B., Yilmaz, M., Knoop, A. & Overgaard, J.: Chalkley estimates of angiogenesis in early breast cancer – relevance to prognosis. Acta Oncologica 41: 695-703, 2002.

665.      Ohneseit, P.A., Wildemann, A., Herskind, C.; Bamberg, M. & Rodemann, H.P.: Differential response of tumor cells and normal fibroblasts to fractionated combined treatment with Topotecan and ionizing radiation. Int. J. Radiat. Biol. 78: 125-132, 2002.

666.      Overgaard, J.: Phase III studies of novel fractionation schedules in radiotherapy of head and neck carcinoma. In: Kogelnik. H.D., Likas, P. & Sedlmayer, F. (eds.): Progress in Radio-Oncology VII. Monduzzi Editore, Bologna, pp. 423-430, 2002.

667.      Safwat A., Bentzen S.M., Turesson I, Hendry J.H.: Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 52: 198-204, 2002.

668.      Schlemmer, B.O.: HER2/neu gen amplifikation ved brystkræft. Kvantitering og evaluering af relation til kliniske data. Speciality thesis, ”Sundhedsfaglige Kandidatuddannelse”, University of Aarhus 2002.

669.      Siemann, D.W. & Horsman, M.R.: Enhancement of radiation therapy by vascular targeting agents. Curr Opin Investig Drugs. 3: 1660-1665, 2002.

670.      Vens, C., Dahmen-Mooren, E., Verwijs-Janssen, M., Blyweert, W., Graversen, L., Bartelink, H. & Begg, A.C.: The role of DANN polymerase beta in determining sensitivity to ionizing radiation in human tumor cells. Nucleic Acids Research 30: 2995-3004, 2002.